Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies

Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies

Triple negative breast cancer (TNBC) is classically treated with combination chemotherapies. Although, initially responsive to chemotherapies, TNBC patients frequently develop drug-resistant, metastatic disease. Chemotherapy resistance can develop through many mechanisms, including induction of a tr...

Full description

Bibliographic Details
Main Authors: Anindita Chakrabarty, Shayantani Chakraborty, Ranjini Bhattacharya, Goutam Chowdhury
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
triple negative breast cancer
chemotherapy
senescence
therapy-induced senescence
senescence-associated stemness
evolution
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.674354/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.674354/full

Similar Items